Your session is about to expire
← Back to Search
Alpha Radiation Device for Advanced Pancreatic Cancer
Study Summary
This trial is testing a new type of treatment for advanced pancreatic cancer that uses a device to emit alpha radiation directly into the tumor.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not pregnant or breastfeeding.I am 18 years old or older.You are expected to live for at least 12 more weeks.You have other health conditions that might affect the goals of the study, such as autoimmune diseases or vasculitis.I am not on long-term immunosuppressive drugs, except for short-term steroids.I have had radiation therapy to my abdomen before.My cancer is advanced or has spread and is a type of pancreatic cancer.I have had chemotherapy before.My largest cancer area is 4cm or smaller.My pancreatic cancer can possibly be removed by surgery and I am healthy enough for the operation.My pancreatic cancer cannot be removed by surgery.I have a connective tissue disease like scleroderma or lupus.You have a tumor that can be measured according to specific guidelines.I can take care of myself but might not be able to do heavy physical work.Women who could become pregnant need to have a negative pregnancy test.I am currently receiving chemotherapy or immunotherapy.
- Group 1: DaRT Seeds
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the stated purpose of this medical experiment?
"This clinical trial aims to evaluate the safety of DaRT seeds insertion through adverse event analysis and assess stent durability, short-term effects, and patient reported quality of life. A CT scan will be used to analyse objective response rate while QoL questionnaires QLQ-PAN26 cover pain, dietary changes, jaundice, altered bowel habit and other symptoms associated with pancreatic cancer."
Is enrollment still possible in this investigation?
"Indeed, data hosted on clinicaltrials.gov certifies that this medical research is currently enrolling patients. It was inaugurated on October 20th 2020 and the most recent update occurred November 21st 2022. The team needs 30 participants from 1 site to complete it's investigation."
To what extent is participation in this medical trial widespread?
"Indeed, the information on clinicaltrials.gov alludes to this ongoing medical trial being open for recruitment. It was initially posted on October 20th 2020 and has since been updated as of November 21st 2022. This study requires 30 participants from one specified site."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger